Airway antibodies emerge according to COVID-19 severity and wane rapidly but reappear after SARS-CoV-2 vaccination
Alberto Cagigi, Meng Yu, Björn Österberg, Julia Svensson, Sara Falck-Jones, Sindhu Vangeti, Eric Åhlberg, Lida Azizmohammadi, Anna Warnqvist, Ryan Falck-Jones, Pia C Gubisch, Mert Ödemis, Farangies Ghafoor, Mona Eisele, Klara Lenart, Max Bell, Niclas Johansson, Jan Albert, Jörgen Sälde, Deleah Pettie, Michael Murphy, Lauren Carter, Neil P King, Sebastian Ols, Johan Normark, Clas Ahlm, View ORCID ProfileMattias Forsell, Anna Färnert, Karin Loré, Anna Smed-Sörensen
doi: https://doi.org/10.1101/2020.11.25.20238592
Alberto Cagigi
1Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
Meng Yu
1Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
Björn Österberg
1Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
Julia Svensson
1Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
Sara Falck-Jones
1Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
Sindhu Vangeti
1Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
Eric Åhlberg
1Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
Lida Azizmohammadi
1Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
Anna Warnqvist
2Division of Biostatistics, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
Ryan Falck-Jones
3Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden
4Department of Perioperative Medicine and Intensive Care, Karolinska University Hospital, Stockholm, Sweden
Pia C Gubisch
1Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
Mert Ödemis
1Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
Farangies Ghafoor
1Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
Mona Eisele
1Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
Klara Lenart
1Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
Max Bell
3Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden
4Department of Perioperative Medicine and Intensive Care, Karolinska University Hospital, Stockholm, Sweden
Niclas Johansson
5Division of Infectious Diseases, Department of Medicine Solna, Center for Molecular Medicine, Karolinska Institutet, Sweden
6Department of Infectious Diseases, Karolinska University Hospital Solna, Stockholm, Sweden
Jan Albert
7Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden
8Clinical Microbiology, Karolinska University Hospital Solna, Stockholm, Sweden
Jörgen Sälde
9Närakut SLSO, Karolinska University Hospital Solna, Stockholm, Sweden
Deleah Pettie
10Department of Biochemistry, University of Washington, Seattle, WA, United States
11Institute for Protein Design, University of Washington, Seattle, WA, United States
Michael Murphy
10Department of Biochemistry, University of Washington, Seattle, WA, United States
11Institute for Protein Design, University of Washington, Seattle, WA, United States
Lauren Carter
10Department of Biochemistry, University of Washington, Seattle, WA, United States
11Institute for Protein Design, University of Washington, Seattle, WA, United States
Neil P King
10Department of Biochemistry, University of Washington, Seattle, WA, United States
11Institute for Protein Design, University of Washington, Seattle, WA, United States
Sebastian Ols
1Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
Johan Normark
12Section of Infection and Immunology, Department of Clinical Microbiology, Umeå university, Umeå, Sweden
Clas Ahlm
12Section of Infection and Immunology, Department of Clinical Microbiology, Umeå university, Umeå, Sweden
Mattias Forsell
12Section of Infection and Immunology, Department of Clinical Microbiology, Umeå university, Umeå, Sweden
Anna Färnert
5Division of Infectious Diseases, Department of Medicine Solna, Center for Molecular Medicine, Karolinska Institutet, Sweden
6Department of Infectious Diseases, Karolinska University Hospital Solna, Stockholm, Sweden
Karin Loré
1Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
Anna Smed-Sörensen
1Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
Data Availability
The data that support the findings os this study are available from the corresponding author on reasonable request.
Posted October 03, 2021.
Airway antibodies emerge according to COVID-19 severity and wane rapidly but reappear after SARS-CoV-2 vaccination
Alberto Cagigi, Meng Yu, Björn Österberg, Julia Svensson, Sara Falck-Jones, Sindhu Vangeti, Eric Åhlberg, Lida Azizmohammadi, Anna Warnqvist, Ryan Falck-Jones, Pia C Gubisch, Mert Ödemis, Farangies Ghafoor, Mona Eisele, Klara Lenart, Max Bell, Niclas Johansson, Jan Albert, Jörgen Sälde, Deleah Pettie, Michael Murphy, Lauren Carter, Neil P King, Sebastian Ols, Johan Normark, Clas Ahlm, Mattias Forsell, Anna Färnert, Karin Loré, Anna Smed-Sörensen
medRxiv 2020.11.25.20238592; doi: https://doi.org/10.1101/2020.11.25.20238592
Airway antibodies emerge according to COVID-19 severity and wane rapidly but reappear after SARS-CoV-2 vaccination
Alberto Cagigi, Meng Yu, Björn Österberg, Julia Svensson, Sara Falck-Jones, Sindhu Vangeti, Eric Åhlberg, Lida Azizmohammadi, Anna Warnqvist, Ryan Falck-Jones, Pia C Gubisch, Mert Ödemis, Farangies Ghafoor, Mona Eisele, Klara Lenart, Max Bell, Niclas Johansson, Jan Albert, Jörgen Sälde, Deleah Pettie, Michael Murphy, Lauren Carter, Neil P King, Sebastian Ols, Johan Normark, Clas Ahlm, Mattias Forsell, Anna Färnert, Karin Loré, Anna Smed-Sörensen
medRxiv 2020.11.25.20238592; doi: https://doi.org/10.1101/2020.11.25.20238592
Subject Area
Subject Areas
- Addiction Medicine (413)
- Allergy and Immunology (728)
- Anesthesia (215)
- Cardiovascular Medicine (3126)
- Dermatology (265)
- Emergency Medicine (464)
- Epidemiology (13076)
- Forensic Medicine (14)
- Gastroenterology (868)
- Genetic and Genomic Medicine (4895)
- Geriatric Medicine (451)
- Health Economics (755)
- Health Informatics (3089)
- Health Policy (1109)
- Hematology (411)
- HIV/AIDS (973)
- Medical Education (457)
- Medical Ethics (121)
- Nephrology (502)
- Neurology (4664)
- Nursing (248)
- Nutrition (691)
- Oncology (2405)
- Ophthalmology (683)
- Orthopedics (270)
- Otolaryngology (333)
- Pain Medicine (311)
- Palliative Medicine (88)
- Pathology (519)
- Pediatrics (1249)
- Primary Care Research (526)
- Public and Global Health (7231)
- Radiology and Imaging (1613)
- Respiratory Medicine (945)
- Rheumatology (462)
- Sports Medicine (403)
- Surgery (518)
- Toxicology (65)
- Transplantation (222)
- Urology (193)